Tegge Jonathan 4
4 · InMed Pharmaceuticals Inc. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Tegge Jonathan
Interim CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-12-16+1,400→ 1,400 totalExercise: $1.78Exp: 2027-12-15→ Common shares (1,400 underlying)
Footnotes (1)
- [F1]Vesting 1/12 per month, in arrears, for 12 months.